A Study of Environmental Effects on the Intestine Bacteria Commonly Present in Children and Adolescents with Multiple Sclerosis
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-001425
Sponsor Protocol Number: 003
About this study
The objective of this study is to understand how commensal (the living together of two organisms in a relationship that is beneficial to one and has no effect on the other) bacteria are associated with MS.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Children are eligible for this study as cases or controls if they are eligible for and enrolled in the Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis study
Exclusion Criteria
- Patients are not eligible for study participation if
- Antibiotics or probiotics have been used within 60 days prior to enrollment
- Steroids have been used within 45 days prior to enrollment
- Ongoing treatment includes any disease-modifying therapy other than glatiramer acetate or interferon
- Disease-modifying therapy treatment agent has changed (including new agent or discontinuation) 90 days or less prior to enrollment
- Children are not eligible to participate as pediatric controls if:
- They are 21 years of age or older
- Antibiotic or probiotics have been used within 60 days prior to enrollment
- Steroids have been used within 45 days prior to enrollment
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Jan-Mendelt Tillema, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available